Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Prochlorperazine edisylate from Heritage/Avet Pharmaceuticals, authorizing continued manufacture and availability of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

SUPPL AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)